Loading...

Hospital Corporation of China Limited

3869.HK•HKSE
Healthcare
Medical - Care Facilities
HK$5.20
HK$0.70(15.56%)

Hospital Corporation of China Limited (3869.HK) Stock Overview

Explore Hospital Corporation of China Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.9/100

Key Financials

Market Cap704.3M
P/E Ratio-16.83
EPS (TTM)$-0.31
ROE-0.11%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$4.98

3869.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hospital Corporation of China Limited (3869.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $4.98.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.83 and a market capitalization of 704.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

100.00RSI (14)
0.17MACD
100.00ADX
Stats data is not available for 3869.HKStats details for 3869.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for 3869.HKAnalyst Recommendations details for 3869.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Hospital Corporation of China Limited, an investment holding company, engages in the operation and management of hospitals in the People's Republic of China. The company provides hospital management and consulting services to Yangsi Hospital, Cixi Hospital, and Jinhua Hospital; and general hospital services. It also engages in the wholesale of pharmaceutical products. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Hospital Corporation of China Limited is a subsidiary of Vanguard Glory Limited.

CEO

Shuai Chen

Employees

1,841

Headquarters

Jin Qiu International Building, Beijing

Founded

2017

Frequently Asked Questions

;